Market Size and Leading Brands
The global under-eye treatment market, which includes depuffing gels, was valued at approximately $6.8 billion in 2023 and is projected to grow at a compound annual growth rate of around 7.5% through 2030, according to Grand View Research. Major consumer goods companies such as L'Oréal, Unilever, and Estée Lauder have expanded their depuffing eye gel portfolios, with L'Oréal's Garnier and Maybelline lines ranking among the top-selling mass-market options. The category increasingly competes with premium medical-grade devices, where companies like Therabody and NuFACE offer FDA-cleared alternatives for reducing under-eye swelling.
Consumer Reports and dermatologist reviews frequently highlight eye gel for puffiness formulations containing caffeine and hyaluronic acid as the most effective non-invasive options. In 2024, Sephora and Ulta Beauty reported that depuffing eye patches and gels were among the fastest-growing skincare subcategories, driven by social media discovery and demand for quick, at-home solutions. The rise of direct-to-consumer brands like The Ordinary and CeraVe has further compressed price points, making eye depuffing treatments accessible to a wider demographic.
Key Ingredients and Clinical Evidence
Caffeine and Peptides
Caffeine is the most widely cited active ingredient in eye gel for puffiness formulations because it constricts blood vessels and reduces fluid retention under the eyes. A 2023 clinical study published in the Journal of Cosmetic Dermatology found that a 2% caffeine eye gel significantly reduced under-eye puffiness and dark circles after four weeks of use. Peptides, particularly palmitoyl tripeptide-5 and copper peptides, are increasingly added to depuffing gels to support microcirculation and strengthen the thin under-eye skin barrier.
Hyaluronic Acid and Cooling Agents
Hyaluronic acid provides immediate plumping and hydration, which temporarily masks the appearance of puffiness by smoothing the skin surface. Many leading eye gels combine hyaluronic acid with cooling agents like menthol or peppermint extract to create a vasoconstriction effect that visibly reduces swelling within minutes. The International Journal of Cosmetic Science notes that combination formulas with both humectants and cooling actives deliver faster perceived results than single-ingredient products.
Regulatory and Safety Considerations
Eye gels for puffiness are classified as cosmetics by the U.S. Food and Drug Administration, meaning they do not require pre-market approval unless they make drug claims such as treating inflammation or edema. The FDA's Center for Food Safety and Applied Nutrition monitors cosmetic products for safety, and companies must comply with the Federal Food, Drug, and Cosmetic Act for labeling and ingredient restrictions. Products containing active pharmaceutical ingredients, like anti-inflammatory agents, must be registered as over-the-counter drugs and submit appropriate data to the agency.
The European Commission's Scientific Committee on Consumer Safety evaluates under-eye treatment ingredients for the EU market, with recent assessments confirming the safety of caffeine and hyaluronic acid at typical cosmetic concentrations. The Cosmetic Ingredient Review panel in the United States has similarly affirmed the safety of most depuffing actives when used as directed. Consumers are advised to check for third-party testing certifications and avoid products with undisclosed proprietary blends that may contain irritants or allergens not listed on the packaging.